PCBL PCBL Chemical Q2 FY26 results (Jul–Sep 2025) and concall
PCBL Chemical Limited reported healthy volume growth and record power generation in Q2 FY26, but profitability was impacted by pricing pressure, US tariffs, and a softer market. Despite these headwinds, the company maintained high capacity utilization and reduced debt. Aquapharm showed mixed performance, with strong India growth offsetting US weakness. PCBL remains optimistic about future growth, driven by strategic capacity expansions and new product development in advanced materials.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 0.0%, net profit down 49.6% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 2,163 | 2,010 | 2,087 | 2,114 | 2,164 +0% |
| EBITDA | 364 | 317 | 298 | 319 | 266 −27% |
| Net profit | 123 | 93 | 100 | 94 | 62 −50% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
